Simon H Stertzer bought $88k of BCDA
director at BioCardia, Inc.. 38,289 shares at an average of $2.30, traded Mar 3, 2025, filed Mar 5, 2025.
Score components
- +15RoleDirector
- +9Trade size$88k at market
- +10Relative to holdingsHoldings up 215%
- +4Price context18% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -20.9%, 3m -14.6%, 6m -19.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-25-006221, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 3, 2025 | POpen-market purchase Common Stock | +22,753 | $2.30 | $52k | 40,602 | Mar 5, 2025 |
| Mar 4, 2025 | POpen-market purchase Common Stock | +15,536 | $2.30 | $36k | 56,138 | Mar 5, 2025 |
Related signals
Other insiders at BioCardia, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $1,030 1,000 shares | +0% | |
| 33Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $1,995 1,900 shares | +0% | |
| 28Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $872 800 shares | +0% | |
| 33Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $5,022 5,400 shares | +1% | |
| 28Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $1,748 1,900 shares | +1% | |
| 43Moderate | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $3,900 5,000 shares | +1% | |
| 38Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $415 500 shares | +0% | |
| 43Moderate | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $3,754 4,300 shares | +1% | |
| 33Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $7,175 7,500 shares | +2% | |
| 33Weak | BCDAbuy BioCardia, Inc. | Peter Altman President and CEO | $5,208 5,400 shares | +2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.